A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxane.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples